VANCOUVER, BC— Clairvoyant Therapeutics, a Canadian biotech company, is pleased to announce it has initiated the first of 15 planned sites for CLARITY, the company’s Phase 2 clinical trial investigating psilocybin… Read More
Highly pure and reproducible; simplifies regulatory medical device approval Improved performance due to highly tunable properties Fermentation-based manufacturing leverages Evonik’s biotechnology platform Evonik’s recombinant, non-animal-derived collagen platform is now available… Read More
VANCOUVER, BC — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to disclose that as part of… Read More
Announcing UBC’s newest Life Science, Lab, and Office Building – TEF4. Inspiring workspace for the brightest minds to realize the biggest ideas. Located at UBC ’s renowned Vancouver campus, this… Read More
The young company is leading a seismic shift in medical research and practice. Robyn Quinn Pharmaceutical companies and researchers have to meet stringent standards for testing new drugs. In the… Read More
